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ABSTRACT
Introduction: We describe a novel device for
rapid and economical minimal erythema dose
testing in patients undergoing ultraviolet (UV)
light phototherapy for treatment of skin
diseases.
Methods: A minimal erythema testing device
was designed and created using transparent
plastic sheeting and printed patterns with
increasing ink density, allowing for graded UV
transmission of 100%, 80%, 60%, 40%, 20%,
and 10% energy through six 10-mm square
apertures. The plastic sheet was placed in a UV-
impenetrable and Velcro-fitted
adjustable sleeve, designed to fit easily onto a
patient’s arm. A pilot validation study was per-
formed, comparing this device with a commer-
cially available windowed device in which the
dose is controlled by varying the UV exposure
time through sequential opening of each win-
dow. The pilot was conducted on healthy skin
of two human subjects with different Fitzpatrick
skin types.
Results: In our subjects, tested with one device
on each forearm, the minimal erythema dose
(MED), judged visually, was identical. However,
the test device allowed MED testing in 3 min
compared with 15 min for the traditional
device. The test device is equally effective for
use with ultraviolet-A (UVA), narrowband
ultraviolet-B (NB-UVB) and broadband ultravi-
olet-B (BB-UVB) wavelengths. The test device is
economical, with manufacturing cost of less
than US $2.
Conclusion: We designed an MED testing device
that is quick, accurate, cost-effective, and easy to
use in the setting of a busy phototherapy practice.
This device therefore has many advantages over
existing MED testing approaches.
Keywords: Broadband ultraviolet-B;
Dermatology; MED testing; Minimal erythema
dose; Narrowband ultraviolet-B; Phototesting;
Phototherapy; Phototherapy device; PUVA;
Ultraviolet light
INTRODUCTION
Ultraviolet (UV) light phototherapy is a well-
established therapy for many common and
uncommon dermatological ailments, including
psoriasis, eczema, generalized itch, cutaneous
lymphoma, and vitiligo. The minimal erythema
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dose (MED) is defined as the lowest dose of UV
light that causes reddening of nondiseased skin
[1]. Determining the MED is important for
establishing a safe and efficacious treatment
dose of UV light. Underestimating the MED
may lead to below-therapeutic UV dosing and
delayed clinical improvement, while overesti-
mating the MED may lead to UV-induced
burning and blistering. Moreover, even after an
individual’s MED is determined and pho-
totherapy is initiated, several clinical situations
may benefit from MED retesting. One example
is if a patient starts a photosensitizing medica-
tion. Another example is if a patient has
received phototherapy for a period of time, but
has recently missed a number of treatments.
While such situations can be approached using
‘‘best guess’’ recalibration of dosing, a quick and
convenient method of accurate MED testing
would be more beneficial.
Existing MED Testing Methods
A crude method used to dose UV light is based
on a person’s Fitzpatrick skin type, defined by a
combination of degree of skin pigmentation
plus patient-reported propensity to burn. In this
approach, the MED is not actually measured but
estimated. While this method is easy and quick,
several studies have established skin typing as
an inexact method of predicting skin sensitivity
to light [2, 3]; For example, there are many
darker-skinned individuals who require a lower
starting UV dose than someone who is more
fair-skinned, and patients’ mental recall of their
burning tendency may be imprecise.
Another approach to MED testing involves
use of a UV-impenetrable template with several
open windows. The template is applied to the
skin, and the windows are sequentially closed
during exposure to UV light, so the test area of
skin is subjected to decreasing fractions of the
maximum dose. Conversely, templates can be
sequentially opened to expose the skin to
increasing fractions of UV (e.g., DosePatch,
Daavlin). In either case, after UV light exposure,
the skin is assessed for redness after 24 h to
determine the MED. The major drawback of this
method is that it is time-consuming, requiring
time to place the device on the patient
(oftentimes requiring tape and towels to shield
surrounding skin) and additional time during
UV light exposure to close or open successive
windows, with an interruption at each step.
Another issue is that this method may also be
inaccurate if the patient shifts position inside
the phototherapy cabinet, causing the distance
and orientation of the patient to the light
source to change. For these reasons, this
method may not be ideal for use in a busy, high-
volume phototherapy practice.
A less commonly used method for MED
testing is a handheld, semiautomated device
that uses its own light source to test a range of
light doses through metal filters [4–8]. A main
drawback to this method is that the device is
expensive, which is cost-prohibitive for many
phototherapy centers. These devices cost several
hundred dollars to purchase, but also require
frequent maintenance. Repair or replacement of
specialized parts adds to the costs of this
method. Another drawback of this method is
that the light source of the MED device is dif-
ferent from that of the phototherapy cabinet in
which the patient will actually be treated, thus
requiring precise calibration of both units.
UV intensity and effects are ultimately deter-
mined by many variables, including the UV light
source, individual differences in skin sensitivity to
light, and the skin’s distance from the light
source. Situational differences in these factors are
the primary sources of error and confusion in the
current MED testing methodology.
Currently, there is no method to perform
MED testing on skin that is simultaneously
convenient, accurate, rapid, and inexpensive.
We describe herein an MED testing device that
conveniently allows for multiple UV light doses
to be tested at once. It can be manufactured at
low cost, allows the user to save time in MED
testing, and utilizes the phototherapy cabinet in
which the patient will be treated.
METHODS
Material Testing
A variety of inexpensive UV-filtering materials
were chosen and tested for effectiveness,
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filtering range, and ease of production. These
included shade paint (VariShade 2, SolarSun,
Inc), transparency sheets, low-density poly-
ethylene, high-density polyethylene,
polyvinylidene chloride, polypropylene, poly-
ethylene terephthalate, and glass of varying
thicknesses. In some cases, the thickness of the
material required to block the appropriate pro-
portion of UV was considered prohibitive. In
other cases, the range of UV filtering was too
narrow for our purposes. The authors ultimately
decided to use a visually transparent, flexible,
UV-filtering base of transparency sheets
(VWO100C-BE, Apollo). This base was also
desirable because patterns may be smoothly
printed onto it to enhance its filtering capability
(045 XL black laser toner cartridge 1246C001,
Canon). Ultimately, an appropriately increasing
gray scale was printed onto the base layer to
attain the desired UV transmission for each
window. To determine the relationship between
the saturation of the ink printed on the trans-
parency and the amount of UV light that was
transmitted, we measured the UV transmitted
through each test print of decreasing saturation
(and thus increasing transparency) and recor-
ded it as a percentage of the UV transmitted
with no filter.
Device Design
The MED testing device comprised several
windows on a clear plastic template
(VWO100C-BE, Apollo) with laser jet ink-prin-
ted shade gradations (045 XL black laser toner
cartridge 1246C001, Canon), housed in a
structural support for fitting onto the arm
(Fig. 1). The device allows a fixed sequence of
discrete fractions of UV light doses to pass
through to the underlying skin. The device is
placed on the skin and exposed to UV light
from the treatment source (i.e., phototherapy
cabinet). A cotton sleeve with windows is used
to block UV from all areas of the exposed arm
except for those tested. The apertures are
shaped like squares so that test results can be
easily distinguished from discoloration of other
common etiologies that present with erythema
(bug bites, angiomas, etc.).
The phototesting template consists of prin-
ted patterns of increasing UV transmission on a
transparent base with six square apertures of
10 mm in width, housed in a UV-impenetrable
sleeve. The aperture that allows the highest UV
light transmission is left open, and is offset such
that the template can be easily matched to the
pattern on the skin upon inspection the next
day. The five remaining apertures attenuate UV
radiation stepwise, resulting in relative intensi-
ties at the skin surface of 80%, 60%, 40%, 20%,
and 10% of total UV light.
Measurement of UV Transmission
UV transmission was measured in the NB-UVB,
BB-UVB, and UVA spectra using light from
standard clinical phototherapy bulbs
(FSX72T12-UVB/HO BB-UVB bulbs by National
Biological Corporation, TL100 W/01 NB-UVB
bulbs by Philips, F72T12/BL/HO PUVA bulbs by
Houvalite). The energy transmission of UV
light was measured using a UV probe meter. The
amount of energy transmitted through each
window of the MED device was measured seri-
ally in the phototherapy cabinet, with the UV
Fig. 1 Test device, comprising a cotton sleeve blocking all
UV with a pocket designed to hold the transparency with
printed filters of increasing absorbance. Inset shows a
zoomed picture of the windows. The lightest window has
no filter or transparency and allows 100% of UV through.
It is offset by half a centimeter from the others to facilitate
realignment with the template for reading MED 24 h later.
The windows are shaped as squares
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probe meter positioned directly behind the
window. The UV bulbs were run for 5 min
before testing began for equilibration, and UV
transmission was first measured with no filter-
ing material to establish a maximum for
comparison.
Data Analysis
Data were recorded and analyzed using Micro-
soft Excel and MATLAB. For each material and
pattern, the filtering capability was defined as
the UV measured at the probe divided by the
maximum UV measured at the probe with no
filtering material, expressed as a percentage. To
define the relationship between the percentage
transparency of the printed grayscale and per-
centage transmission of UV light, MATLAB’s
curve-fitting toolbox was used. The data were fit
using both a sigmoidal fit and a linear fit for
comparison. We employed the method of
nonlinear least squares to find the best fit for
each equation type, allowing two free fit coef-
ficients, a and b, for each. The linear equation
was of the form
y ¼ axþ b;
while the sigmoidal equation was of the form
y ¼ 100
1þ eb xað Þ :
For the sigmoidal function, the constant
describing the upper horizontal asymptote of
the function was set at 100, chosen because it is
the maximum possible transmission of UV.
In Vivo Validation
The device for in vivo validation comprised a
cotton sleeve with square windows of 10 mm in
width, with the window receiving the most UV
positioned off-center from the others for posi-
tion verification upon inspection the next day.
Beneath the windows in the sleeve was the UV-
filtering material with increasing levels of UV-
blocking gray scale pattern. The device was
positioned on the forearm of two volunteers
with Fitzpatrick skin type II and III, and was
exposed to up to 800 mJ/cm2 of UV light in a
NB-UVB phototherapy booth. The area was
examined 24 h postexposure to determine
MED. Informed consent was obtained from all
participants in the study.
RESULTS
First, we wanted to determine the relationship
between the saturation of the ink printed on the
transparency and the amount of UV light that
was transmitted. To do this, we measured the
UV transmitted through each test print of
decreasing saturation (and thus increasing
transparency) and recorded it as a percentage of
total UV. We performed this for nbUVB,
bbUVB, and UVA. Theoretically, the function
describing this data is sigmoidal in nature, with
upper and lower horizontal asymptotes at 100%
UV transmission and 0% UV transmission
accordingly. Indeed, the data were best
approximated by the sigmoidal equation, with a
resulting R2 of 0.99 (Fig. 2, nbUVB shown). A
linear function returned a good but less ideal fit
to the data, resulting in an R2 of 0.97.
For in vivo testing, we housed the UV filters
in a cotton sleeve (Fig. 1). The printed insert
containing the filters was placed inside a spe-
cially designed pocket in the sleeve with cutouts
for the testing windows. The sleeve allowed
Fig. 2 Percent transmitted UV demonstrates sigmoidal
relationship with percent printed transparency. Black dots
represent measured UV at each tested filter as a percentage
of total with no filter. Black line is the line of best fit for
these data points. R2 = 0.998, a = 64.4, b = 0.044
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coverage of the rest of the arm while exposing
only the 10 9 10 mm testing sites. After 24 h,
the subjects’ MED was determined as the lowest
dose at which there was redness. This was
compared with a windowed device (DosePatch,
Daavlin) in which each window received a cal-
culated cumulative dose of UV to correspond
with the percentages of UV transmitted by the
filters of the device. The MED was ascertained
visually by two physicians, and was shown to be
the same between the new and traditional MED
devices for each subject (Fig. 3).
The overall time to complete testing with the
new device was approximately 3 min, including
the time to put on the sleeve, tighten it with the
Velcro fastener, slip on a glove to protect the
hand, and complete testing in the phototherapy
cabinet. In comparison, the overall time to
complete testing with the windowed standard
device was approximately 15 min, in part due to
the longer time starting and stopping delivery
of UV light in the cabinet, and in part due to the
longer time required to cover the exposed areas
of skin around the windows. Once in the pho-
totherapy cabinet, the time to finish testing
with the device was approximately 3 min and
30 s less than with the industry-standard win-
dowed option. The entire cost of the device is
less than US $2, and this cost could be reduced




The novel MED device described herein per-
formed accurate and efficient MED testing using
a novel, cost-effective design. Testing of UV
transmittance shows a large range of target
values that may be easily allowed by the device.
This range is from approximately 8% transmit-
tance to 83% transmittance, bounded by the
UV blocking capability of the ink and the
baseline UV blocking of the transparency
material, respectively. Because the transmit-
tance between these bounds can be titrated by
changing the saturation of print, any desired
percentage of total UV is attainable. The
amount of saturation needed varies approxi-
mately linearly with the transparency of the
print, particularly for the transparency range
[30% (Fig. 2).
The accuracy of this method was demon-
strated with two volunteers with different Fitz-
patrick skin types, and it was noted that the skin
had the same reaction to either receiving
cumulative doses of UV to attain a total UV dose
or receiving UV that was filtered to transmit
decreasing fractions of energy. Both the win-
dowed approach and the test device yielded the
same MED measurement on each volunteer.
With regard to efficiency, the device reduced
the time in the phototherapy cabinet by
approximately one-half for each subject.
Fig. 3 MED testing results on the left and right forearms
of a subject with Fitzpatrick type II. a Results with test
device. b Results with windowed device. MED is visually
judged at 60% of total UV for each. Black dots mark the
outline of the window through which UV passed
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Moreover, in total, the time spent using this
device was one-fifth of the time spent on the
peel-away standard windowed device used as a
comparator.
Advantages of Present Device Compared
with Commercially Available MED Testing
Methods
The device described herein is advantageous
because it eliminates many sources of error and
confusion in the established MED testing
methods. These advantages include ease of use,
time efficiency, accuracy, error minimization,
and economic value.
Whereas other devices may vary the expo-
sure time and thus require multiple exposures,
the device presented herein is fast and conve-
nient to use since it requires only a single UV
exposure for complete and accurate MED test-
ing. This is because the device was designed to
deliver different UV doses by varying the irra-
diance through each aperture of the device. This
time-saving is compatible with the workflow of
a high-throughput dermatology practice. Such
efficiency of testing may also improve patient
and provider satisfaction.
Shorter duration of testing, and fixed doses
of light determined by the device itself, elimi-
nate the human error inherent in the more
time-consuming, traditional MED testing tem-
plates. With regard to the design of the device,
the configuration of the windows is asymmet-
ric, thus preventing uncertainty regarding
which window is associated with which UV
dose. The device is more accurate than other
methods utilizing separate light sources, in part
because it is designed to be used with the same
light source that will be used in the patient’s
subsequent treatments. Because it works with
the exact phototherapy bulbs that the patient
will be using for future therapy, UV output
mismatch between different machines is not a
concern.
The device’s filters work similarly to the
aforementioned handheld semiautomated
device, which uses expensive neutral-density
filters and its own light source. However, in
contrast to these semiautomated devices, this
device is inexpensive; it is not part of a larger
machine with its own light source. Without the
need for electrical wiring, circuitry, or bulbs, the
device is inexpensive and thus accessible to
potential customers. Since the device is eco-
nomical, it can easily be streamlined for mass
production or customized for individual MED
testing needs, thus increasing its cost-effective-
ness and applicability.
Limitations
Although the described device has been
designed to precisely filter various doses of UV
light as measured by an objective UV probe
meter, it has only been validated in two subjects
with Fitzpatrick skin type II and III. Therefore,
future studies should examine the performance
of the device in a larger number of subjects with
the full range of skin types.
CONCLUSIONS
The capability of this novel device to deliver
several multiple UV doses at once will allow
managing physicians to perform MED testing to
determine optimal treatment dosing for
patients efficiently and accurately. This device is
an improvement over Fitzpatrick skin type
estimates, because it allows the individual to be
tested for skin reaction to UV light objectively.
It is an improvement over cumulative UV dose
testing because it does not require the practi-
tioner to stop and restart the UV dosing every
1–2 min to adjust skin exposure. It is an
improvement over handheld devices that deli-
ver different amounts of UV light because it
does not require the purchase of additional UV-
producing equipment requiring maintenance.
In summary, the device introduced herein is
uniquely able to address the various shortcom-
ings of the currently available MED testing
methods. In doing so, it allows for increased
therapeutic efficacy and reduced side effects in
phototherapy. It is a rapid, economical, and
accurate solution to allow for MED testing in a
high-throughput, busy dermatological pho-
totherapy practice.
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